Consequently, inhibition of chitinases AMCase and CHIT1, and also of the chitinase-like protein YKL-40 (CHI3L1), may prove a viable strategy for treatment of inflammatory and fibrotic diseases, including colitis [21,28,29]. This evidence concerns the gene CHI3L1 and colitis.